Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Apr 7, 2025
8-K Apr 4, 2025 8-K
424B4 Apr 4, 2025 424B4
S-1/A Apr 1, 2025 S-1/A
S-1/A Mar 27, 2025 S-1/A
S-1/A Mar 27, 2025 S-1/A
S-1/A Mar 25, 2025 S-1/A
8-K Mar 20, 2025 8-K
4 Mar 4, 2025 4
4 Mar 4, 2025 4
4 Mar 4, 2025 4
4 Mar 4, 2025 4
S-1 Mar 3, 2025 S-1
EFFECT Feb 26, 2025
CORRESP Feb 24, 2025
UPLOAD Feb 21, 2025
S-3 Feb 14, 2025 S-3
10-K Feb 14, 2025 10-K
8-K Feb 14, 2025 8-K
8-K Feb 11, 2025 8-K
SCHEDULE 13G/A Feb 10, 2025
SCHEDULE 13G/A Feb 10, 2025
EFFECT Jan 2, 2025
CORRESP Jan 2, 2025
UPLOAD Dec 30, 2024
← Newer Page 7 of 30 · 732 filings Older →